Search
for
Sort by
Research 361–390 of 1000+
- Hair casts
- Cutaneous thrombosis and ANCA-positive vasculitis associated with propylthiouracil therapy
- Œdème angioneurotique sans anomalie de l’inhibiteur de la C1 estérase : efficacité de l’acide tranexamique
- Alopecia Areata is associated with MICA and an extended HLA haplotype
- Primary Cicatricial Alopecias
- Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study
- CHRONIC TELOGEN EFFLUVIUM
- Cystoid macular oedema in uveitis: An unsolved problem
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Cronkhite-Canada syndrome associated with colon cancer metastatic to liver
- Cutaneous Markers of Disorders Affecting Adult Horses
- Short Anagen Syndrome in an Indian Woman with its Impact on Quality-of-Life
- Ovarian Leydig cell hyperplasia as a rare cause of hair loss in a postmenopausal female patient: a case report and diagnostic approach toward postmenopausal hyperandrogenism
- Effects of a cyclosporine-based protocol in canine granulomatous sebaceous adenitis - case series
- SEBACEOUS ADENITIS IN AKITA DOG – CASE REPORT
- Prevalence of Non-Scarring Alopecia among Female Patients Complaining from Hirsutism
- DERMOSCOPIC EVALUATION OF THERAPEUTIC RESPONSE IN ALOPECIA AREATA
- Lichenoid red tatoo reaction and alopecia areata
- Clinical study on 88 cases of Korean 20-nail dystrophy
- Abstracts Pt.30
- Manual of chemical peels: Superficial and medium depth
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Telogen effluvium
- Diagnosis of hyperandrogenism: clinical criteria
- Toxic Epidermal Necrolysis
- Telogen effluvium
- Dermatology of androgen-related disorders
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser